Laslo Roman
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Oncology 25
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 6
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 5
- Co-authors
- Tadeusz PieńkowskiYoung‐Hyuck ImJosé Luiz PedriniSeock‐Ah ImGraham RossJavier CortésJosé BaselgaSandra M. Swain
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (8 papers)Gynecologic Oncology (2 papers)The Lancet Oncology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- RussiaUnited StatesSpain
In The Last Decade
Laslo Roman
30 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 4.4k
- Cancer Research 1.4k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Pulmonary and Respiratory Medicine 1.3k
- Hepatology 293
Countries citing papers authored by Laslo Roman
This map shows the geographic impact of Laslo Roman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laslo Roman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laslo Roman more than expected).
Fields of papers citing papers by Laslo Roman
This network shows the impact of papers produced by Laslo Roman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laslo Roman. The network helps show where Laslo Roman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laslo Roman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 16 | |
| 2 | 2018 | 12 | |
| 3 | 2017 | 0 | |
| 4 | 2017 | 2 | |
| 5 | 2016 | 1 | |
| 6 | 2015 | 60 | |
| 7 | 2014 | 75 | |
| 8 | 2014 | 2 | |
| 9 | 2014 | 35 | |
| 10 | 2014 | 2 | |
| 11 | 2013 | 29 | |
| 12 | 2013 | 158 | |
| 13 | 2013 | 3 | |
| 14 | 2013 | 110 | |
| 15 | 2012 | 9 | |
| 16 | Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Hit paper breakdown → | 2011 | 1773 |
| 17 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Hit paper breakdown → | 2011 | 1535 |
| 18 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 755 |
| 19 | 2010 | 415 | |
| 20 | 1995 | 121 |
About Laslo Roman
Laslo Roman is a scholar working on Oncology, Cancer Research, Obstetrics and Gynecology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 5.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Oncology (4.4k citations), Cancer Research (1.4k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Hepatology (293 citations). Laslo Roman has collaborated with scholars based in Russia, United States and Spain. Frequent co-authors include Tadeusz Pieńkowski, Young‐Hyuck Im, José Luiz Pedrini, Seock‐Ah Im, Graham Ross, Javier Cortés, José Baselga, Sandra M. Swain, Roberto Hegg and Mark Benyunes. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Gynecologic Oncology, The Lancet Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.